Category: FDA & Regulatory Policy

March 13, 2019

Alliance Statement on FY 2020 White House Proposed Budget

Alliance for Aging Research President and CEO Susan Peschin, MHS, issued the following statement in response to the White House’s…
June 15, 2018

ACT-AD Coalition Letter on FDA Early Alzheimer’s Disease Guidance

The majority of clinical trials conducted in Alzheimer’s disease have been for patients who received a definitive diagnosis after becoming…
July 12, 2017

Five Questions (and Answers) about the FDA Reauthorization Act of 2017

Right now, the U.S. Congress is considering the FDA Reauthorization Act of 2017 , legislation that will reauthorize the pharmaceutical, medical device, generic drug, and biosimilar user fee agreements. The five-year deal is one of the most important health care bills Congress will vote on this year.
May 23, 2017

Alliance Statement on FY 2018 White House Proposed Budget on NIH, FDA, CDC

Alliance President and CEO Susan Peschin, MHS, has issued the following statement in response to the White House’s proposed Fiscal Year 2018 budget.
April 27, 2017

Alliance Thanks Senate HELP Committee for Advancing FDA Commissioner Nomination of Dr. Scott Gottlieb

Alliance for Aging Research President and CEO Susan Peschin, MHS, has issued the following statement thanking Chairman Lamar Alexander and the U.S. Senate HELP Committee for advancing the nomination of Dr. Scott Gottlieb as U.S. Food and Drug Administration (FDA) commissioner to the full Senate for a vote.
April 21, 2017

Tomorrow Is the March for Science

This Saturday, April 22, thousands of people will gather in the shadow of the Washington Monument to march for not just a cause, but in support of one of humanity’s most important endeavors: science.
April 4, 2017

Alliance’s Bens Offers Testimony on User Fee Programs before Senate HELP Committee

Today, the Alliance for Aging Research's (Alliance) Vice President of Public Policy Cynthia Bens testifies before the U.S. Senate HELP Committee on reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA).
April 3, 2017

Alliance Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner

Alliance for Aging Research President and CEO Susan Peschin, MHS, has issued a statement in support of the nomination of Scott Gottlieb, M.D., to be commissioner of the U.S. Food and Drug Administration (FDA).
March 28, 2017

Alliance’s Bens Offers Testimony on MDUFA before House Committee

Today, the Alliance for Aging Research's Vice President of Public Policy Cynthia Bens testifed before the U.S. House of Representatives' Energy and Commerce Committee, Subcommittee on Health, in regard to reauthorization of the Medical Device User Fee Act (MDUFA).
March 27, 2017

Testimony before Energy and Commerce Committee, Subcommittee on Health, on Examining FDA’s Medical Device User Fee Program

On March 28, Alliance for Aging Research Vice President of Public Policy Cynthia Bens testified before the United States House of Representatives' Energy and Commerce Committee, Subcommittee on Health, at its hearing on the FDA’s Medical Device User Fee Program.